$SUNL

Insider Buying week 12-03-21 -Let me Count the Ways I Hate SPACS

by

Curious how well insiders are doing with their buys? Click on this link or image above to scroll the significant buys of the last year. I’ve been monitoring insider behavior and how it impacts stock prices for about as long as anyone out there I haven’t seen much that shocks me or changes my perception of the usefulness of this information.  Now I have.  Normally significant insider buying will put a floor on a down-trending stock.  That’s changed with SPACS.  No matter how encouraging the news is or robust the insider buying is, when you have big shareholders waiting in … Read more

The Bold, the Inexplicable and the Good Soldiers- Insider Buying Week 9-17-21

by

For trade, details click on this link to the trades.  There were quite a few buys last week and it took me longer than usual to update it. Also, I will provide a brief recap of the conversation I had with the Chief Medical Officer, Alexander A. Zukiwski at Casi Pharmaceuticals. Casi is a U.S. NASDAQ-listed biotech selling exclusively to the increasingly affluent Chinese middle class.  CASI is a penny stock that will turn into $dollars if things pan out the way I think. They have one approved revenue-producing product with an exciting pipeline. There is a high probability they … Read more